Cardiomyopathy Trial, Recruiting (NCT07491718)

Cardiomyopathy Trial, Recruiting NCT07491718 Sponsor: University of Edinburgh Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT07491718 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are male or female and over 18 years old
You have been diagnosed with a condition called takotsubo cardiomyopathy (sometimes called "broken heart syndrome")
You are able to understand and agree to take part by giving formal consent

Who may not be able to join:

You are unable to have an MRI scan, or an MRI scan is not safe for you for any reason
You have significant kidney problems, which would be checked with a blood test
You have a previous history of any type of heart muscle disease (cardiomyopathy)
You are currently pregnant
You weigh more than 250kg
You have severe asthma — this applies to one part of the study (confirm with trial site)
You have Type 1 diabetes — this applies to one part of the study (confirm with trial site)
You have significantly low blood pressure, as some medications used in this study can lower blood pressure further
You have a significantly slower than normal heart rate — this applies to one part of the study (confirm with trial site)
You are currently taking a medication called Digoxin, as it may interact with something used in this study
You are unable to understand or agree to take part by giving formal consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01316501000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07491718

Sponsor: University of Edinburgh

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: 01316501000

More information: https://clinicaltrials.gov/study/NCT07491718

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are male or female and over 18 years old
You have been diagnosed with a condition called takotsubo cardiomyopathy (sometimes called "broken heart syndrome")
You are able to understand and agree to take part by giving formal consent

Who may not be able to join:

You are unable to have an MRI scan, or an MRI scan is not safe for you for any reason
You have significant kidney problems, which would be checked with a blood test
You have a previous history of any type of heart muscle disease (cardiomyopathy)
You are currently pregnant
You weigh more than 250kg
You have severe asthma — this applies to one part of the study (confirm with trial site)
You have Type 1 diabetes — this applies to one part of the study (confirm with trial site)
You have significantly low blood pressure, as some medications used in this study can lower blood pressure further
You have a significantly slower than normal heart rate — this applies to one part of the study (confirm with trial site)
You are currently taking a medication called Digoxin, as it may interact with something used in this study
You are unable to understand or agree to take part by giving formal consent

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Edinburgh

Registry

ClinicalTrials.gov

Start date

8 August 2025

Est. completion

9 August 2028

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Left ventricular myocardial manganese uptake.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov